259 related articles for article (PubMed ID: 3558010)
1. [Results of an interdisciplinary study of primary inoperable stage T3 and T4 squamous cell carcinoma of the mouth, oropharynx and hypopharynx].
Rohrmeier M; Langnickel R; Hilpert P
HNO; 1987 Jan; 35(1):14-8. PubMed ID: 3558010
[TBL] [Abstract][Full Text] [Related]
2. [Cytostatic primary therapy of squamous cell carcinoma of the oro- and hypopharynx with cisplatin, bleomycin and methotrexate].
Deitmer T; Urbanitz D
Laryngol Rhinol Otol (Stuttg); 1986 Jan; 65(1):7-10. PubMed ID: 2419720
[TBL] [Abstract][Full Text] [Related]
3. [Critical remarks on the chemotherapy of squamous cell carcinomas of the oropharynx].
Arnhold-Schneider M; Polyzoidis T
HNO; 1987 Nov; 35(11):468-71. PubMed ID: 3692932
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy in early-stage and locally advanced small bulk squamous cell carcinoma of the oral cavity and oropharynx.
Tichler T; Ramon Y; Rath P; Hendler S; Brenner HJ
Isr J Med Sci; 1988; 24(9-10):539-44. PubMed ID: 2462551
[TBL] [Abstract][Full Text] [Related]
5. [Pathohistologic studies of serial sections of squamous cell cancer of the oral cavity and oropharynx following cytostatic induction therapy with bleomycin and cisplatin].
Bettinger R; Meyer-Breiting E; Klima A
Laryngol Rhinol Otol (Stuttg); 1988 Nov; 67(11):580-5. PubMed ID: 2467153
[TBL] [Abstract][Full Text] [Related]
6. [Current role for induction chemotherapy in head and neck tumors].
Dietz A; Keilholz U; Werner J; Hagen R; Flentje M; Iro H
Laryngorhinootologie; 2008 Apr; 87(4):237-43; discussion 244. PubMed ID: 18365986
[TBL] [Abstract][Full Text] [Related]
7. Intra-arterial chemoradiation for T3-4 oral cavity cancer: treatment outcomes in comparison to oropharyngeal and hypopharyngeal carcinoma.
Doweck I; Robbins KT; Samant S; Vieira F
World J Surg Oncol; 2008 Jan; 6():2. PubMed ID: 18194553
[TBL] [Abstract][Full Text] [Related]
8. Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume.
Bisdas S; Nguyen SA; Anand SK; Glavina G; Day T; Rumboldt Z
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1313-8. PubMed ID: 18963541
[TBL] [Abstract][Full Text] [Related]
9. [Induction chemotherapy of carcinomas of the oral cavity and oropharynx. Feasibility study, levels and factors of response to treatment. Apropos of 135 cases].
Calais G; Goga D; Le Flock O; Ballon G
Rev Stomatol Chir Maxillofac; 1987; 88(5):359-64. PubMed ID: 2448863
[TBL] [Abstract][Full Text] [Related]
10. [Induction chemotherapy in cancer of the upper respiratory and digestive tract. Preliminary results of the protocol combining cisplatin, 5-fluorouracil and bleomycin (CFB)].
Laccourreye H; Bassot V; Lacau St Guily J; Brasnu D; Menard M; Donnadieu S; Jacquillat C
Ann Otolaryngol Chir Cervicofac; 1985; 102(1):1-6. PubMed ID: 2408533
[TBL] [Abstract][Full Text] [Related]
11. [The remission of extensive cancers of the mouth and oropharynx with intra-arterial polychemotherapy with vincristine, methotrexate, bleomycin, cisplatin (VMBP)].
Mika H
Laryngol Rhinol Otol (Stuttg); 1982 Sep; 61(9):520-3. PubMed ID: 6183545
[TBL] [Abstract][Full Text] [Related]
12. [Preliminary results of a prospective randomized study of primary chemotherapy in carcinoma of the oral cavity and pharynx].
Volling P; Schröder M
HNO; 1995 Feb; 43(2):58-64. PubMed ID: 7713766
[TBL] [Abstract][Full Text] [Related]
13. French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC).
Bensadoun RJ; Bénézery K; Dassonville O; Magné N; Poissonnet G; Ramaïoli A; Lemanski C; Bourdin S; Tortochaux J; Peyrade F; Marcy PY; Chamorey E; Vallicioni J; Seng H; Alzieu C; Géry B; Chauvel P; Schneider M; Santini J; Demard F; Calais G
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):983-94. PubMed ID: 16376489
[TBL] [Abstract][Full Text] [Related]
14. [The role of a surgical method in combined and complex treatment of patients with squamous cell oral and oropharyngeal cancer].
Vikhlianov IV; Shoĭket IaN; Lazarev AF
Khirurgiia (Mosk); 2007; (1):55-8. PubMed ID: 17426691
[TBL] [Abstract][Full Text] [Related]
15. [Preoperative radiochemotherapy in advanced oral and oropharyngeal carcinoma].
Dobrowsky W; Dobrowsky E; Rausch EM; Strassl H; Braun O
Strahlenther Onkol; 1987 Jun; 163(6):357-60. PubMed ID: 3110983
[TBL] [Abstract][Full Text] [Related]
16. [Simultaneous squamous cell carcinomas of the oral cavity and oropharynx].
Ricard AS; Majoufre-Lefebvre C; Demeaux H; Siberchicot F; Zwetyenga N
Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):509-12. PubMed ID: 17881023
[TBL] [Abstract][Full Text] [Related]
17. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
Layland MK; Sessions DG; Lenox J
Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
[TBL] [Abstract][Full Text] [Related]
18. Squamous cell carcinoma of the oropharynx and hypopharynx.
Lin DT; Cohen SM; Coppit GL; Burkey BB
Otolaryngol Clin North Am; 2005 Feb; 38(1):59-74, viii. PubMed ID: 15649499
[TBL] [Abstract][Full Text] [Related]
19. Multimodal intensification regimens for advanced, resectable, previously untreated squamous cell cancer of the oral cavity, oropharynx, or hypopharynx: a 12-year experience.
Schuller DE; Ozer E; Agrawal A; Grecula JC; Rhoades CA; Young DC
Arch Otolaryngol Head Neck Surg; 2007 Apr; 133(4):320-6. PubMed ID: 17438244
[TBL] [Abstract][Full Text] [Related]
20. [Effect of chemotherapy on the survival of patients with far-advanced squamous cell carcinoma of the head and neck. A comparative matched-pair analysis of conventional therapeutic procedures with and without chemotherapy].
Schröder M; von Heyden HW; Scherpe A; Nagel GA
Laryngol Rhinol Otol (Stuttg); 1986 Jan; 65(1):11-5. PubMed ID: 2419719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
